293 related articles for article (PubMed ID: 28774281)
21. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
22. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
23. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
24. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
Wentzensen N; Schiffman M; Dunn T; Zuna RE; Gold MA; Allen RA; Zhang R; Sherman ME; Wacholder S; Walker J; Wang SS
Int J Cancer; 2009 Nov; 125(9):2151-8. PubMed ID: 19585494
[TBL] [Abstract][Full Text] [Related]
25. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China.
Li M; Du X; Lu M; Zhang W; Sun Z; Li L; Ye M; Fan W; Jiang S; Liu A; Wang M; Meng Y; Li Y
J Med Virol; 2019 Mar; 91(3):473-481. PubMed ID: 30281807
[TBL] [Abstract][Full Text] [Related]
26. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
[TBL] [Abstract][Full Text] [Related]
27. Effect of smoking on high-grade cervical cancer in women on the basis of human papillomavirus infection studies.
Fang JH; Yu XM; Zhang SH; Yang Y
J Cancer Res Ther; 2018; 14(Supplement):S184-S189. PubMed ID: 29578171
[TBL] [Abstract][Full Text] [Related]
28. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
29. The prevalence, genotype distribution of human papillomavirus and cervical cytology in Wenzhou, China: a retrospective research of 7391 cases.
Lin Q; Lin X; Zhuang X; Tang Y; Zhao Z
Diagn Cytopathol; 2021 Feb; 49(2):211-218. PubMed ID: 32965784
[TBL] [Abstract][Full Text] [Related]
30. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.
Sehnal B; Dusek L; Cibula D; Zima T; Halaska M; Driak D; Slama J
J Clin Virol; 2014 Jan; 59(1):18-23. PubMed ID: 24315797
[TBL] [Abstract][Full Text] [Related]
31. Genotype distribution of human papillomavirus (HPV) in histological sections of cervical intraepithelial neoplasia and invasive cervical carcinoma in Madrid, Spain.
García-Espinosa B; Moro-Rodríguez E; Alvarez-Fernández E
BMC Cancer; 2012 Nov; 12():533. PubMed ID: 23167826
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer.
Salavatiha Z; Farahmand M; Shoja Z; Jalilvand S
J Med Virol; 2021 Aug; 93(8):4647-4658. PubMed ID: 33694179
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India.
Bhatla N; Dar L; Rajkumar Patro A; Kumar P; Pati SK; Kriplani A; Gulati A; Broor S; Iyer VK; Mathur S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2008 Jul; 27(3):426-30. PubMed ID: 18580322
[TBL] [Abstract][Full Text] [Related]
35. Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea.
Jung S; Lee B; Lee KN; Kim Y; Oh EJ
Arch Pathol Lab Med; 2016 Mar; 140(3):276-80. PubMed ID: 26927723
[TBL] [Abstract][Full Text] [Related]
36. Screening for HPV infection in exfoliated cervical cells of women from different ethnic groups in Yili, Xinjiang, China.
Pan Z; Song Y; Zhe X; Wang W; Zhu J; Zheng W; Li H; Li D; Cao D; Pan Z; Shao R
Sci Rep; 2019 Mar; 9(1):3468. PubMed ID: 30837516
[TBL] [Abstract][Full Text] [Related]
37. Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women.
Pista A; Oliveira A; Verdasca N; Ribeiro F
Clin Microbiol Infect; 2011 Jun; 17(6):941-6. PubMed ID: 21040156
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
Pista A; de Oliveira CF; Lopes C; Cunha MJ;
Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.
Siddiqa A; Zainab M; Qadri I; Bhatti MF; Parish JL
Viruses; 2014 Jul; 6(7):2762-77. PubMed ID: 25036463
[TBL] [Abstract][Full Text] [Related]
40. [Human papillomavirus genotype distribution in cervical infections among woman in La Plata, Argentina].
Abba MC; Gomez MA; Golijow CD
Rev Argent Microbiol; 2003; 35(2):74-9. PubMed ID: 12920987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
